Skip to main content
Premium Trial:

Request an Annual Quote

Citing Economic Uncertainty, Bruker Sheds 10 Percent of Workforce in US, Germany

Click here for an updated version of this story.


NEW YORK, July 8 - Bruker Daltonics said today that "on-going uncertain economic conditions" has forced it to lay off roughly 10 percent of its workforce in the United States and Germany.


"As demand in several customer segments is experiencing slower growth, we are taking decisive action to reduce our cost structure," said Frank Laukien, president and CEO. "Once fully implemented, we expect cost savings of about $2.5 million next year."

Calling the move "aggressive," Bruker said the lay offs come at a time when the company faces slowed bookings among pharma, biotech, and chemical customers. Bruker, which posted 22-percent growth in second-quarter year-over-year bookings, also blamed the decrease on the departure of distributor companies like Variagenics and Perkin-Elmer.


However, Bruker said booking have grown among universities, medical schools, governments, and nonprofit groups, and the company said it expects "strategic sales" to grow for the rest of the year through Agilent and Sequenom.

"Fundamentally, our life-science research and pharma/biotech markets have healthy long-term trends, and we see strong funding for our life-science systems based on mass spectrometry, due to their enabling role in critical fields like genotyping, proteomics and metabolomics," said Laukien.

The Scan

Sick Newborns Selected for WGS With Automated Pipeline

Researchers successfully prioritized infants with potential Mendelian conditions for whole-genome sequencing or rapid whole-genome sequencing, as they report in Genome Medicine.

Acne-Linked Loci Found Through GWAS Meta-Analysis

Researchers in the European Journal of Human Genetics find new and known acne vulgaris risk loci with a genome-wide association study and meta-analysis, highlighting hair follicle- and metabolic disease-related genes.

Retina Cell Loss Reversed by Prime Editing in Mouse Model of Retinitis Pigmentosa

A team from China turns to prime editing to correct a retinitis pigmentosa-causing mutation in the PDE6b gene in a mouse model of the progressive photoreceptor loss condition in the Journal of Experimental Medicine.

CRISPR Screens Reveal Heart Attack-Linked Gene

Researchers in PLOS Genetics have used CRISPR screens to home in on variants associated with coronary artery disease that affect vascular endothelial function.